Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Shopping For Deals That Will Add $25bn To 2030 Revenues

Feb 09 2022

• By Jessica Merrill

shopping cart — Pfizer has money to spend on deals • Source: Alamy

Related Content

Pfizer Is Changed ‘Forever’ By COVID-19; Revenue Forecast Hits Triple Digits

Feb 08 2022

A Biopharma M&A Bonanza In 2022? Analysts Pick Top Targets And Likely Buyers

Feb 02 2022

Pfizer Buys Arena For $6.7bn In Bid To Diversify In Inflammation & Immunology

Dec 13 2021

Beam Anticipates Pfizer Deal Will Lead To Additional Partnerships

Jan 12 2022

Deals Or No Deals, J.P. Morgan Sets The Tone For 2022

Jan 13 2022

J.P. Morgan Day 1: Pharma Execs Offer Big Talk Instead Of Big Deals

Jan 11 2022

Related Companies

Pfizer Inc.

Johnson & Johnson

Novartis AG

Arena Pharmaceuticals, Inc.

Beam Therapeutics Inc.

BioNTech SE

Acuitas Therapeutics

Telesis Bio, Inc

Additional Topics

Deals Leadership M & A Business Strategies BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.